|
|||||
|
|
Phase I,Randomized, Double‐Blind,Placebo‐Controlled,Multiple Intravenous,Dose‐Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus |
|
| Authors: | Jacek C. Szepietowski Surasak Nilganuwong Anna Wozniacka Annegret Kuhn Filippa Nyberg Ronald F. van Vollenhoven Anders A. Bengtsson Adam Reich Dick E. de Vries Bart van Hartingsveldt Donald W. Robinson Robert Gordon Benjamin Hsu |
| Abstract: | |
| Keywords: | |